A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Monday 19 October 2009

Losartan and Caspofungin in Denmark

As you may recall, the Blog reported that an application was made for the paediatric extension of Caspofungin in Denmark in February this year. Andreas Schmitt of A.S. Dataservices writes:
"Denmark has recently granted pediatric extensions for Losartan and Caspofungin (see here for page of Patent Journal).
The expiry date given for Caspofungin doesn't take the extension into account, but after contacting the Danish Patent Office, they informed me that the date will be corrected in one of the next issues of the journal."

No comments: